Concentrix Corp.

{
  "main_header": {
    "sid": 1285752,
    "name": "Concentrix Corp.",
    "stock_name": "Concentrix Corp.",
    "full_name": "Concentrix Corp.",
    "name_url": "stocks-analysis/concentrix-corp",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "41.74",
    "chg": -14.09,
    "chgp": "-25.24%",
    "dir": -1,
    "prev_price": "55.83",
    "mcapval": "3,328.84",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US20602D1019",
    "curr_date": "Jan 21",
    "curr_time": "",
    "bse_nse_vol": "766.06 k",
    "exc_status": "Active",
    "traded_date": "Jan 21, 2026",
    "traded_date_str": "2026 01 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concentrix-corp-1285752-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Concentrix Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-concentrix-corp-overvalued-or-undervalued-3673429",
        "imagepath": "",
        "date": "2025-11-05 11:11:28",
        "description": "As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears undervalued relative to its peers, with a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison, Genpact Ltd. has a P/E of 14.38 and an EV to EBITDA of 10.34, while ADT, Inc. shows a P/E of 10.02 and an EV to EBITDA of 5.12, highlighting Concentrix's more favorable valuation metrics.\n\nDespite its attractive valuation, Concentrix has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -9.87% compared to the S&P 500's 16.30%. This underperformance may suggest that the market has not yet recognized the company's potential, reinforcing the notion that Concentrix is undervalued...."
      },
      {
        "title": "Is Concentrix Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-concentrix-corp-overvalued-or-undervalued-3670623",
        "imagepath": "",
        "date": "2025-11-04 11:17:27",
        "description": "As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison to peers, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, reinforcing Concentrix's relative attractiveness.\n\nDespite this favorable valuation, Concentrix has underperformed against the S&P 500, with a year-to-date return of -8.48% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 65.62%, suggests that while the company is currently undervalued, market sentiment may still be weighing heavily on its stock price...."
      },
      {
        "title": "Is Concentrix Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-concentrix-corp-overvalued-or-undervalued-3666192",
        "imagepath": "",
        "date": "2025-11-03 11:16:50",
        "description": "As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, supported by a P/E ratio of 11, a price-to-book value of 0.90, and an EV to EBITDA ratio of 5.71. In comparison, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, highlighting Concentrix's relative attractiveness in the market.\n\nDespite the positive valuation indicators, Concentrix has underperformed against the S&P 500, with a year-to-date return of -6.84% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 67.02% against a 76.66% gain for the S&P 500, suggests that while the company is currently undervalued, market sentiment may still be a concern...."
      },
      {
        "title": "Is Concentrix Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-concentrix-corp-overvalued-or-undervalued-3664324",
        "imagepath": "",
        "date": "2025-11-02 11:09:52",
        "description": "As of 31 October 2025, the valuation grade for Concentrix Corp. moved from fair to attractive, indicating a positive shift in its valuation outlook. The company is currently considered undervalued, supported by a P/E ratio of 11, a price-to-book value of 0.90, and an EV to EBITDA ratio of 5.71. In comparison, Genpact Ltd. has a P/E ratio of 14.38, while ADT, Inc. shows a P/E of 10.02, suggesting that Concentrix Corp. is priced more favorably relative to its peers.\n\nDespite the attractive valuation, Concentrix has underperformed against the S&P 500, with a year-to-date return of -6.84% compared to the index's 16.30%. This performance highlights a potential disconnect between market perception and intrinsic value, reinforcing the view that Concentrix Corp. is undervalued...."
      }
    ],
    "total": 16,
    "sid": "1285752",
    "stock_news_url": "https://www.marketsmojo.com/news/concentrix-corp-1285752"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Concentrix Corp. overvalued or undervalued?

2025-11-05 11:11:28

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears undervalued relative to its peers, with a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison, Genpact Ltd. has a P/E of 14.38 and an EV to EBITDA of 10.34, while ADT, Inc. shows a P/E of 10.02 and an EV to EBITDA of 5.12, highlighting Concentrix's more favorable valuation metrics. Despite its attractive valuation, Concentrix has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -9.87% compared to the S&P 500's 16.30%. This underperformance may suggest that the market has not yet recognized the company's potential, reinforcing the notion that Concentrix is undervalued....

Read full news article

Is Concentrix Corp. overvalued or undervalued?

2025-11-04 11:17:27

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison to peers, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, reinforcing Concentrix's relative attractiveness. Despite this favorable valuation, Concentrix has underperformed against the S&P 500, with a year-to-date return of -8.48% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 65.62%, suggests that while the company is currently undervalued, market sentiment may still be weighing heavily on its stock price....

Read full news article

Is Concentrix Corp. overvalued or undervalued?

2025-11-03 11:16:50

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, supported by a P/E ratio of 11, a price-to-book value of 0.90, and an EV to EBITDA ratio of 5.71. In comparison, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, highlighting Concentrix's relative attractiveness in the market. Despite the positive valuation indicators, Concentrix has underperformed against the S&P 500, with a year-to-date return of -6.84% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 67.02% against a 76.66% gain for the S&P 500, suggests that while the company is currently undervalued, market sentiment may still be a concern....

Read full news article

Is Concentrix Corp. overvalued or undervalued?

2025-11-02 11:09:52

As of 31 October 2025, the valuation grade for Concentrix Corp. moved from fair to attractive, indicating a positive shift in its valuation outlook. The company is currently considered undervalued, supported by a P/E ratio of 11, a price-to-book value of 0.90, and an EV to EBITDA ratio of 5.71. In comparison, Genpact Ltd. has a P/E ratio of 14.38, while ADT, Inc. shows a P/E of 10.02, suggesting that Concentrix Corp. is priced more favorably relative to its peers. Despite the attractive valuation, Concentrix has underperformed against the S&P 500, with a year-to-date return of -6.84% compared to the index's 16.30%. This performance highlights a potential disconnect between market perception and intrinsic value, reinforcing the view that Concentrix Corp. is undervalued....

Read full news article

View All News